NSC |
Compound |
Enrichment |
Correlation |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0286383688883668 |
0.31295639 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0286383688883668 |
-0.15540508 |
NSC 166199 |
Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) |
0.0286383688883668 |
0.49682583 |
NSC 168516 |
Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- |
0.0286383688883668 |
-0.10233072 |
NSC 237671 |
Actinomycin X4357g-methoxime |
0.0286383688883668 |
0.27855757 |
NSC 295499 |
Camptothecin Derivative |
0.0286383688883668 |
0.49717174 |
NSC 330507 |
Tanespimycin |
0.0286383688883668 |
0.021563861 |
NSC 55720 |
Phosphinic acid, bis(1-aziridinyl)-, 2-naphthalenyl ester (9CI) |
0.0286383688883668 |
0.3174361 |
NSC 615803 |
1H-Benz[de]isoquinoline-1,3(2H)-dione, 2,2'-[1,2- ethanediylbis(imino-3,1-propanediyl)]bis[5,8-dinitro-, dihydrochloride |
0.0286383688883668 |
0.35425696 |
NSC 621457 |
Pyrimidine-2-amine, 5-chloro-6-(2-hydroxy-5-chlorophenyl)- 4-phenyl- |
0.0286383688883668 |
-0.19775055 |